Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

630
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
630

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endo-SemiS: Towards Robust Semi-Supervised Image Segmentation for Endoscopic Video.

Proceedings of machine learning research·2026
Same author

Kidney Endoscopy Video to Preoperative CT Alignment for Depth Estimation.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

AVA: Automated Viewability Analysis for Ureteroscopic Intrarenal Surgery.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Choroid plexus calcification detection using quantitative susceptibility mapping MRI.

medRxiv : the preprint server for health sciences·2026
Same author

Perseus: perception with semantic endoscopic understanding and SLAM.

International journal of computer assisted radiology and surgery·2026
Same author

Quantitative imaging of iron dysregulation in multiple system atrophy.

NeuroImage·2026
Same journal

Generative morphodynamic forecasting enables robust zero-shot volumetric medical segmentation.

Medical image analysis·2026
Same journal

ContiMorph: An unsupervised learning framework for cardiac motion tracking with time-continuous diffeomorphism.

Medical image analysis·2026
Same journal

MedP-CLIP: Medical CLIP with region-aware prompt integration.

Medical image analysis·2026
Same journal

Multi-organ guided diagnosis of mild cognitive impairment via hierarchical alignment and knowledge distillation.

Medical image analysis·2026
Same journal

SUDA: Simultaneous unsupervised knowledge distillation and adaptation of foundation models for efficient pathological image analysis.

Medical image analysis·2026
Same journal

Beyond the LUMIR challenge: The pathway to foundational registration models.

Medical image analysis·2026
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K

Multi-scale graph-based grading for Alzheimer's disease prediction.

Kilian Hett1, Vinh-Thong Ta2, Ipek Oguz3

  • 1CNRS, Univ. Bordeaux, Bordeaux INP, LABRI, UMR5800, PICTURA, Talence F-33400, France; Vanderbilt University, Department of Electrical Engineering and Computer Science, Nashville, TN, USA.

Medical Image Analysis
|October 19, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a novel MRI-based biomarker to predict Alzheimer's disease progression in mild cognitive impairment (MCI) patients. The new method accurately identifies individuals likely to convert to Alzheimer's disease (AD) within three years.

Keywords:
Alzheimer’s disease classificationGraph-based methodHippocampal subfieldsInter-subject similarityIntra-subject variabilityMild cognitive impairmentPatch-based gradingWhole brain analysis

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Related Experiment Videos

Last Updated: Dec 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Alzheimer's Disease Research

Background:

  • Predicting progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is crucial for treatment development.
  • Current methods require improved accuracy in identifying individuals at high risk of conversion.

Purpose of the Study:

  • To develop and validate a new MRI-based biomarker for predicting MCI to AD conversion.
  • To enhance the accuracy of early Alzheimer's disease detection using advanced neuroimaging analysis.

Main Methods:

  • A novel graph-based grading framework combining inter-subject similarity and intra-subject variability features.
  • Patch-based grading of anatomical structures and graph-based modeling of structure alteration relationships.
  • An innovative multiscale brain analysis using a cascade of classifiers to assess alterations at various anatomical levels, including the hippocampus.

Main Results:

  • The proposed multiscale graph-based grading method achieved an Area Under the Curve (AUC) of 81% for predicting MCI to AD conversion within three years on the ADNI-1 dataset.
  • Integration with cognitive scores further improved prediction accuracy, reaching 85% AUC.
  • Performance is competitive with existing state-of-the-art methods.

Conclusions:

  • The developed MRI-based biomarker demonstrates high accuracy in predicting Alzheimer's disease progression in MCI subjects.
  • The multiscale graph-based approach effectively captures the signature of Alzheimer's disease.
  • This biomarker holds potential for accelerating clinical trials and improving patient outcomes.